Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Business groups oppose SB 1122 as pharmacy, physician groups support PBM regulation
Summary
The Senate Health and Human Services Committee heard competing testimony on SB 1122, a bill that would extend certain state requirements to additional health benefit plans and tighten prohibitions on PBM steering practices.
The Senate Health and Human Services Committee heard extensive testimony on Senate Bill 1122, which would extend certain state requirements to a broader set of health benefit plans and tighten prohibitions on pharmacy benefit manager (PBM) ‘‘steerage’’ practices, according to witnesses. Testimony included sharply divided views from business groups, health plans, physician organizations and pharmacy associations.
Glenn Hammer, president and CEO of the Texas Association of Business, opposed SB 1122 and said the bill would increase costs for employers and disrupt the ERISA framework that governs many employer‑sponsored plans. “We respectfully believe that SB 1122 threatens this goal by significantly increasing costs for businesses,” Hammer said, and argued that added state…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
